Show
Sort by
-
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
-
- Journal Article
- A2
- open access
Pushing the boundaries : concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy : a case report
-
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial
(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188 -
- Journal Article
- A1
- open access
Association of chemotherapy timing in pregnancy with congenital malformation
-
- Journal Article
- A1
- open access
The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
-
- Journal Article
- A1
- open access
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited : a European Network for Individualized Treatment of Endometrial Cancer collaboration study
-
- Journal Article
- A1
- open access
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model : a development and validation study.
-
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer
-
Poor outcome in hypoxic endometrial carcinoma is related to vascular density
-
Treatment of ovarian cancer with intraperitoneal platinum : heating up the debate